How much funding has Pheon Therapeutics raised?

Pheon Therapeutics has raised $188.0M in total funding, most recently a series b round.

Who are Pheon Therapeutics's investors?

Pheon Therapeutics's investors include Atlas Venture, TCG Crossover, Brandon Capital Partners, Forbion Capital Partners.

When was Pheon Therapeutics founded?

Pheon Therapeutics was founded in 2022.

Where is Pheon Therapeutics headquartered?

Pheon Therapeutics is headquartered in Harpenden, United Kingdom.

What industry is Pheon Therapeutics in?

Pheon Therapeutics operates in Biotech, Healthcare.

How many employees does Pheon Therapeutics have?

Pheon Therapeutics has 11-50 employees.

Pheon Therapeutics

Developing next generation ADCs for a wide range of hard-to-treat cancers

Harpenden, United Kingdom · Founded 2022 · $188.0M raised

Biotech

Healthcare

Headquarters: Harpenden
Employees: 11–50
Founded: 2022
Business Model: B2B

Website: pheontx.com
Total Funding: $188.0M
Last Round: $120.0M Series BMay 2024
Rounds: 2

About

Pheon Therapeutics is a UK-based ADC specialist developing a pipeline of monotherapies for novel targets and/or novel payloads, targeting hard-to-treat solid tumors. Founded in 2022 and headquartered at the Lawes Open Innovation Hub in Harpenden, UK, Pheon raised $188M across Series A and B to advance its ADC platform.

Summary

Pheon Therapeutics is a Biotech company based in Harpenden, United Kingdom, founded in 2022. It has raised $188.0M in total across 2 rounds, most recently a $120.0M Series B round in May 2024. Investors include Atlas Venture, TCG Crossover and Brandon Capital Partners.